Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...
A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...
Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...
David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...
AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...
Clinical-stage biotech Dianthus Therapeutics develops antibody therapies for severe autoimmune and neuromuscular conditions.
After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...
Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...
Robertet has invested in Aethera Biotech to boost its expertise in biotech and grow its health and beauty division. The French fragrance and flavours manufacturer first partnered with the Italian firm ...
The Chosun Ilbo on MSN
KOSDAQ leadership shifts to biotech amid market volatility
The leading stocks in the KOSDAQ market are rapidly being reshuffled. With the top market cap position changing five times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results